Provided by Tiger Trade Technology Pte. Ltd.

Rani Therapeutics Holdings

0.8121
-0.0167-2.01%
Post-market: 0.8038-0.0083-1.02%16:49 EDT
Volume:232.17K
Turnover:189.87K
Market Cap:113.20M
PE:-3.74
High:0.8372
Open:0.8128
Low:0.7900
Close:0.8288
52wk High:3.87
52wk Low:0.4453
Shares:139.40M
Float Shares:85.67M
Volume Ratio:0.40
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2174
EPS(LYR):-0.4500
ROE:-172.15%
ROA:-52.99%
PB:2.89
PE(LYR):-1.80

Loading ...

Rani Therapeutics RaniPill Platform Joins FDA Emerging Technology Program

Reuters
·
Oct 05

Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (Etp)

THOMSON REUTERS
·
Oct 05

H.C. Wainwright Sticks to Their Buy Rating for Rani Therapeutics Holdings (RANI)

TIPRANKS
·
Sep 22

Rani Therapeutics Management to Attend Lake Street BIG10 Growth Conference

Reuters
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Sanofi (OtherSNYNF)

TIPRANKS
·
Aug 24

Chardan Initiates Rani Therapeutics Holdings at Buy With $6 Price Target

MT Newswires Live
·
Aug 18

Emmaus Life Sciences Q2 Revenue Soars on Licensing Deal

Reuters
·
Aug 15

Inflammation Drug Developer HCW Biologics' Q2 Net Loss Widens

Reuters
·
Aug 15

VistaGen Q1 Revenue Rises on Licensing Agreement Expiration

Reuters
·
Aug 14

Rani Therapeutics Q2 FY26 Net Loss Narrows to USD 8.42 Million; Revenue Turns to USD 1.71 Million

Reuters
·
Aug 14

Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update

THOMSON REUTERS
·
Aug 14

Rani Therapeutics Q2 Operating Expenses USD 10.536 Million

THOMSON REUTERS
·
Aug 14

Rani Therapeutics to Present at Canaccord Genuity Annual Growth Conference

Reuters
·
Aug 10

Rani Therapeutics Names Michelle Gilson to Board as Audit Committee Chair

Reuters
·
Aug 04

Rani Therapeutics Appoints Michelle Gilson to Board of Directors

THOMSON REUTERS
·
Aug 04

Canaccord Genuity Remains a Buy on Rani Therapeutics Holdings (RANI)

TIPRANKS
·
Jul 30

Sagimet, PNC, United Rentals, Rani, Southern Copper Insider Shake-Up

TIPRANKS
·
Jul 25

Top Insider Makes Bold Move on Rani Therapeutics Stock

TIPRANKS
·
Jul 24

Rani Therapeutics Director, 10% Owner Mir A. Imran Buys 36,000 Shares Worth $24,840

Reuters
·
Jul 24

Rani Therapeutics CEO Imran Talat Acquires 35,000 Shares Worth $25,193

Reuters
·
Jul 22